Skip to main content
Premium Trial:

Request an Annual Quote

Jennifer Doudna and Emmanuelle Charpentier

CRISPR researchers Jennifer Doudna of the University of California, Berkeley and Emmanuelle Charpentier of the Max Planck Institute for Infection Biology have been awarded the 2017 Japan Prize.

The Japan Prize Foundation said it was honoring their work on "deciphering the molecular details of the type II bacterial immune system CRISPR/Cas and the creation of the CRISPR/Cas9 genome editing system."

The Japan Prize is awarded each year to researchers in two pre-selected fields. This year's fields were "Life Science" and "Electronics, Information, and Communication."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.